SPECTRX, INC.
Table of Contents

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): December 13, 2005 (December 13, 2005)

SPECTRX, INC.
(Exact Name of Registrant as Specified in Its Charter)

         
Delaware
(State or Other Jurisdiction of Incorporation)
  0-22179
(Commission File Number)
  58-2029543
(IRS. Employer Identification No.)
     

4955 Avalon Ridge Pkwy, Suite 300
Norcross, Georgia

(Address of Principal Executive Offices)

 

30071
(Zip Code)

Registrant's Telephone Number, Including Area Code:     (770) 242-8723


(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions :

 

o                                    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o                                    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o                                    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o                                    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 


TABLE OF CONTENTS

Item 8.01. OTHER EVENTS.
  Item 9.01. FINANCIAL STATEMENTS AND EXHIBITS.
SIGNATURES
EXHIBIT INDEX
Exhibit 99.1 Press Release, dated December 13, 2005.


Table of Contents

Item 8.01.          Other Events.

     

On December 13, 2005 , the registrant publicly announced that it was granted key patent for non-invasive cervical cancer detection technology, as more fully described in the press release, a copy of which is furnished as Exhibit 99.1 hereto and which information is incorporated herein by reference.
 


Table of Contents

 

Item 9.01.         Financial Statements and Exhibits.

                    (c)      Exhibits.

     The following exhibit is filed or furnished with this report:

     
Exhibit No.   Exhibit Description

 
99.1   Press Release, dated December 13, 2005

 


Table of Contents

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

         
    SPECTRX, INC.
 
         
 
   
/s/ MARK A. SAMUELS

    By:   Mark A. Samuels
        CEO & CFO
 
         
 
Date: December 13, 2005.        

 


Table of Contents

EXHIBIT INDEX

     
Exhibit No.   Exhibit Description

 
99.1   Press Release, dated December 13, 2005